Chronic kidney disease prevalence has surged in the USA, primarily due to factors like hypertension, diabetes, autoimmune disorders, polycystic kidney disease, and prolonged urinary tract issues. The escalating incidences of kidney failure are anticipated to propel the United States dialysis services market growth. As chronic kidney disease progresses to end-stage renal disease (ESRD), necessitating dialysis or kidney transplantation, services addressing this critical need are crucial.
In the USA about 35.5 million people are suffering from chronic kidney disease, which is about 1 in 7 individuals in the country. The age group of 65+ are largely affected by chronic kidney disease, contributing to 33.70%.
Fig: Percentage of US Adults Aged 18 Years and Older with Chronic Kidney Disease
Further, the rising prevalence of diabetes and hypertension underscores the importance of dialysis services, as these conditions significantly increase the risk of kidney failure. The US dialysis services market is driven by the imperative to meet the escalating demand for advanced renal care solutions.
Further, increasing innovations and research and development activities are expected to support the market for dialysis services. In February 2024, Fresenius Medical Care received FDA clearance for its 5008X Hemodialysis System, aiming to introduce a new standard of care for individuals with kidney diseases in the U.S. This innovative system, already successful in other regions, utilises high-volume haemodiafiltration, a technique combining diffusion and convection to effectively remove toxins and manage fluid replacement.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Breakup by Type, End Use, and Region:
- Based on type, the market is segmented into haemodialysis and peritoneal dialysis.
- By end use, the market is segmented into dialysis center, hospital, and home healthcare.
- Region-wise, the US dialysis services market is divided into New England, Mideast, Great Lakes, Plains, Southeast, Southwest, Rocky Mountain, and Far West.
Key Findings of the Report:
- Chronic Kidney Disease (CKD) prevalence in the USA has increased due to factors such as hypertension, diabetes, autoimmune disorders, polycystic kidney disease, and prolonged urinary tract issues, affecting approximately 35.5 million people, or 1 in 7 individuals in the country.
- The rising prevalence of diabetes and hypertension amplifies the necessity for dialysis services, as these conditions significantly heighten the risk of kidney failure, further emphasizing the importance of meeting the growing demand for advanced renal care solutions.
- Rising innovations and R&D investments in dialysis are supporting the market growth.
Key Offerings of the Report:
- The EMR report gives an overview of the United States dialysis services market for the periods (2017-2023) and (2024-2032).
- The report also offers historical (2017-2023) and forecast (2024-2032) market information for the type, end use, and major regions of dialysis services.
- The report analyses the market dynamics, covering the key demand and price indicators in the market, along with providing an assessment of the SWOT and Porter’s Five Forces models.
The major players in the United States dialysis services market are Fresenius Medical Care AG & Co, KGaA, DaVita Inc., U.S. Renal Care, Inc., Dialysis Clinic, Inc., Satellite Healthcare, Baxter International, Inc., Northwest Kidney Center, and American Renal Associates (Innovative Renal Care), among others. The comprehensive report by EMR looks into the market share, capacity, and latest developments like mergers and acquisitions, plant turnarounds, and capacity expansions of the major players.
Key Highlights of the Report
| REPORT FEATURES |
DETAILS |
| Base Year |
2023 |
| Historical Period |
2017-2023 |
| Forecast Period |
2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Type |
- Hemodialysis
- Peritoneal Dialysis
|
| Breakup by End Use |
- Dialysis Center
- Hospital
- Home Healthcare
|
| Breakup by Region |
- New England
- Mideast
- Great Lakes
- Plains
- Southeast
- Southwest
- Rocky Mountain
- Far West
|
| Market Dynamics |
- SWOT Analysis
- Porter's Five Forces Analysis
- Key Indicators for Demand
- Key Indicators for Price
|
| Competitive Landscape |
- Market Structure
- Company Profiles
- Company Overview
- Product Portfolio
- Demographic Reach and Achievements
- Certifications
|
| Companies Covered |
- Fresenius Medical Care AG & Co, KGaA
- DaVita Inc.
- U.S. Renal Care, Inc.
- Dialysis Clinic, Inc.
- Satellite Healthcare
- Baxter International, Inc.
- Northwest Kidney Center
- American Renal Associates (Innovative Renal Care)
- Others
|
About Us
Expert Market Research (EMR) is a leading market research and business intelligence company, ensuring its clients remain at the vanguard of their industries by providing them with exhaustive and actionable market data through its syndicated and custom market reports, covering over 15 major industry domains. The company's expansive and ever-growing database of reports, which are constantly updated, includes reports from industry verticals like chemicals and materials, food and beverages, energy and mining, technology and media, consumer goods, pharmaceuticals, agriculture, and packaging.
EMR leverages its state-of-the-art technological and analytical tools, along with the expertise of its highly skilled team of over a 100 analysts and more than 3000 consultants, to help its clients, ranging from Fortune 1000 companies to small and medium sized enterprises, easily grasp the expansive industry data and help them in formulating market and business strategies, which ensure that they remain ahead of the curve.
Contact Us
Expert Market Research
Website: www.expertmarketresearch.com
Email: [email protected]
US & Canada Phone no: +1-415-325-5166
UK Phone no: +44-702-402-5790
